Organisms Function: Dna Synthesis and Epiphany Moment

organisms function: While existing biotechnology is already used to make medicines like insulin and genetically modified crops, synthesizing whole genes or genomes gives an opportunity for far more extensive changes, according to The Japan Times. Matt Ocko, a Silicon Valley venture capitalist whose past investments include Facebook, Uber and Zynga believes the emerging industry has passed the epiphany moment needed to prove it can deliver economic value. Despite ethical and safety concerns, investors are attracted by synthetic biology's wide market potential and the plummeting cost of DNA synthesis, which is industrializing the writing of the genetic code that determines how organisms function. Synthetic biology companies are now becoming more like the disruptive, industrial-scale value propositions that define any technology business, he said. That makes it easier to extract disruptive value. The things that sustain and accelerate this industry are today more effective, lower cost, more precise and more repeatable. (news.financializer.com). As reported in the news.